UBLCP1 antibody
Principal name
UBLCP1 antibody
Alternative names for UBLCP1 antibody
Ubiquitin-like domain-containing CTD phosphatase 1
SwissProt ID
Q2KJD7 (Bovin), Q5FWT7 (Rat), Q5ZJJ8 (Chick), Q641F1 (Xenla), Q8BGR9 (Mouse), Q8WVY7 (Human)
Ncbi ID
9606, NP_659486, NP_659486.2, NM_145049, NP_077795.2, NM_024475, NM_001014117
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of UBLCP1 antibody
- Kit Component:
- - KN318609G1, Ublcp1 gRNA vector 1 in pCas-Guide vector
- KN318609G2, Ublcp1 gRNA vector 2 in pCas-Guide vector
- KN318609D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Zheng H., et al. (2005) Biochem. Biophys. Res. Commun. 331:1401-1407
UBLCP1 MaxPab polyclonal antibody. Western Blot analysis of UBLCP1 expression in human placenta.
Western Blot analysis of UBLCP1 expression in transfected 293T cell line (H00134510-T01) by UBLCP1 MaxPab polyclonal antibody.Lane 1: UBLCP1 transfected lysate(34.98 KDa).Lane 2: Non-transfected lysate.
Mouse CD4 T; . Lanes: 1: CD4 T cell lysate from WT mice, 2: CD4 T cell lysate from WT mice treated with anti-CD3/CD28, 3: CD4 T cell lysate from WT mice treated with FK506, 4: CD4 T cell lysate from WT mice treated with anti-CD3/CD28 and FK506, 5: CD4 T cell lysate from TRPV1 KO mice, 6: CD4 T cell lysate from TRPV1 KO mice treated with anti-CD3/CD28, 7: CD4 T cell lysate from TRPV1 KO mice treated with FK506, 8: CD4 T cell lysate from TRPV1 KO mice treated with anti-CD3/CD28 and FK506.. Primary Antibody Dilution: 1:1000. Secondary Antibody: Anti-rabbit HRP. Secondary Antibody Dilution: 1:10,000. Gene Name: UBLCP1. Submitted by: Christine Quinley, UCSD.; UBLCP1 antibody - N-terminal region (ARP52791_P050) in Mouse CD4 T cells using Western Blot
Human Thymus; WB Suggested Anti-UBLCP1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Human Thymus; UBLCP1 antibody - N-terminal region (ARP52791_P050) in Human Thymus cells using Western Blot
Human HepG2; WB Suggested Anti-UBLCP1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: HepG2 cell lysate; UBLCP1 antibody - N-terminal region (ARP52790_P050) in Human HepG2 cells using Western Blot
WB Suggested Anti-UBLCP1 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 62500; Positive Control: HepG2 cell lysate
WB Suggested Anti-UBLCP1 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 1562500; Positive Control: Human Thymus
Lanes: 1: CD4 T cell lysate from WT mice, 2: CD4 T cell lysate from WT mice treated with anti-CD3/CD28, 3: CD4 T cell lysate from WT mice treated with FK506, 4: CD4 T cell lysate from WT mice treated with anti-CD3/CD28 and FK506, 5: CD4 T cell lysate from
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP302342 | UBLCP1 |
||||
| Recombinant protein of human ubiquitin-like domain containing CTD phosphatase 1 (UBLCP1) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
